Garjae Dayan Lavien, MD - Medicare Urology in Saint Paul, MN

Garjae Dayan Lavien, MD is a medicare enrolled "Urology" physician in Saint Paul, Minnesota. He went to University Of North Carolina At Chapel Hill School Of Medicine and graduated in 2010 and has 14 years of diverse experience with area of expertise as Urology. He is a member of the group practice Healthpartners Medical Group and his current practice location is 435 Phalen Blvd, Mail Stop 51103c, Saint Paul, Minnesota. You can reach out to his office (for appointments etc.) via phone at (651) 254-8500.

Garjae Dayan Lavien is licensed to practice in Minnesota (license number 60491) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1659695310.

Contact Information

Garjae Dayan Lavien, MD
435 Phalen Blvd, Mail Stop 51103c,
Saint Paul, MN 55130
(651) 254-8500
Not Available



Physician's Profile

Full NameGarjae Dayan Lavien
GenderMale
SpecialityUrology
Experience14 Years
Location435 Phalen Blvd, Saint Paul, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Garjae Dayan Lavien attended and graduated from University Of North Carolina At Chapel Hill School Of Medicine in 2010
  NPI Data:
  • NPI Number: 1659695310
  • Provider Enumeration Date: 03/23/2010
  • Last Update Date: 08/13/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 2860703394
  • Enrollment ID: I20160721000385

Medical Identifiers

Medical identifiers for Garjae Dayan Lavien such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1659695310NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 60491 (Minnesota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Regions HospitalSaint paul, MNHospital
Park Nicollet Methodist HospitalSaint louis park, MNHospital
Lakeview Memorial HospitalStillwater, MNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Healthpartners Medical Group17592939541430

News Archive

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

UB researchers develop aniontransporters to trigger cancer cell apoptosis

The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Garjae Dayan Lavien allows following entities to bill medicare on his behalf.
Entity NamePark Nicollet Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780621904
PECOS PAC ID: 7911819438
Enrollment ID: O20031104000046

News Archive

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

UB researchers develop aniontransporters to trigger cancer cell apoptosis

The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.

Read more Medical News

› Verified 5 days ago

Entity NameGroup Health Plan Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710924683
PECOS PAC ID: 1759293954
Enrollment ID: O20031105000417

News Archive

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

UB researchers develop aniontransporters to trigger cancer cell apoptosis

The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Garjae Dayan Lavien is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Garjae Dayan Lavien, MD
8170 33rd Ave S, Ms 21110q,
Bloomington, MN 55425-4516

Ph: (651) 254-8500
Garjae Dayan Lavien, MD
435 Phalen Blvd, Mail Stop 51103c,
Saint Paul, MN 55130

Ph: (651) 254-8500

News Archive

Can-Fite BioPharma reports Q1 2015 financial results, provides updates on drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.

Teva, Active Biotech report positive initial results from laquinimod Phase III study in multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

UB researchers develop aniontransporters to trigger cancer cell apoptosis

The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.

Read more News

› Verified 5 days ago


Urology Doctors in Saint Paul, MN

Michael Howard Wipf, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 360 Sherman St, Suite 400, Saint Paul, MN 55102
Phone: 651-999-6800    Fax: 651-999-6910
Dr. Joshua Lane Woelk, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1021 Bandana Blvd E Ste 100, Saint Paul, MN 55108
Phone: 651-241-9700    Fax: 651-241-9678
Peter Donald Sershon, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102
Phone: 651-999-6800    Fax: 651-999-6810
Michael Lee Pergament, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 360 Sherman St, Suite 400, Saint Paul, MN 55102
Phone: 651-999-6800    Fax: 651-999-6910
Walter Paul Gleich, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102
Phone: 651-999-6800    Fax: 651-999-6808
Robert David Fisher, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102
Phone: 651-999-6800    Fax: 651-999-6910
Jesse Jacobs,
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 435 Phalen Blvd, Saint Paul, MN 55130
Phone: 651-254-8500    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.